These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Warfarin: is the end nigh? Please? Neilson RF J R Coll Physicians Edinb; 2010 Sep; 40(3):222-3. PubMed ID: 21127766 [No Abstract] [Full Text] [Related]
8. What are the emerging therapeutic alternatives to warfarin in stroke patients? How would the results of RE-LY benefit Pakistanis? Khan M; Raza E; Kamal AK J Pak Med Assoc; 2011 Jun; 61(6):612-3. PubMed ID: 22204226 [No Abstract] [Full Text] [Related]
9. Quality of anticoagulation control in atrial fibrillation. Lane DA; Lip GY Lancet; 2010 Sep; 376(9745):935-7. PubMed ID: 20801499 [No Abstract] [Full Text] [Related]
10. Dabigatran and warfarin in vitamin K antagonist-naive and -experienced cohorts with atrial fibrillation. Ezekowitz MD; Wallentin L; Connolly SJ; Parekh A; Chernick MR; Pogue J; Aikens TH; Yang S; Reilly PA; Lip GY; Yusuf S; Circulation; 2010 Nov; 122(22):2246-53. PubMed ID: 21147728 [TBL] [Abstract][Full Text] [Related]
11. Dabigatran versus warfarin for patients with non-valvular atrial fibrillation: is the patient the winner? Grave S Aust Nurs J; 2011 Dec-2012 Jan; 19(6):30-3. PubMed ID: 22329103 [TBL] [Abstract][Full Text] [Related]
12. [Dabigatran versus Warfarin in patients with atrial fibrillation. Results of the RE-LY study]. Liakishev AA Kardiologiia; 2009; 49(10):75-6. PubMed ID: 19845524 [No Abstract] [Full Text] [Related]
15. Anticoagulation: improve care quality or use new alternatives? You JH Lancet; 2011 Feb; 377(9764):464-5; author reply 465. PubMed ID: 21296230 [No Abstract] [Full Text] [Related]
16. Stroke prophylaxis with warfarin or dabigatran for patients with non-valvular atrial fibrillation-cost analysis. Ali A; Bailey C; Abdelhafiz AH Age Ageing; 2012 Sep; 41(5):681-4. PubMed ID: 22378612 [TBL] [Abstract][Full Text] [Related]
17. [New drug in atrial fibrillation--how does it function in regular health care?]. Holmström M; Johnsson H; Lärfars G; Malmström R; Hjemdahl P Lakartidningen; 2009 Nov 4-12; 106(45):3019-20. PubMed ID: 19998831 [No Abstract] [Full Text] [Related]
18. Dabigatran etexilate in people with atrial fibrillation. Raju NC; Hankey GJ BMJ; 2010 Jul; 341():c3784. PubMed ID: 20671015 [No Abstract] [Full Text] [Related]
19. Do ingredients make the difference?: finding the best cocktail of an anticoagulant with antiplatelets. Sinnaeve PR; Van de Werf F Circulation; 2013 Feb; 127(5):566-8. PubMed ID: 23271795 [No Abstract] [Full Text] [Related]
20. Dabigatran etexilate versus warfarin as the oral anticoagulant of choice? A review of clinical data. Ma TK; Yan BP; Lam YY Pharmacol Ther; 2011 Feb; 129(2):185-94. PubMed ID: 20920530 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]